Standout Papers
- Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial (2020)
- Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial (2020)
Immediate Impact
2 by Nobel laureates 4 from Science/Nature 64 standout
Citing Papers
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
Works of Prasheen Agarwal being referenced
Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)
2021
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Prasheen Agarwal | 1003 | 639 | 942 | 27 | 1.6k | |
| Jonathan S. Coblyn | 1204 | 436 | 454 | 34 | 2.0k | |
| S. Kary | 1600 | 857 | 662 | 23 | 2.2k | |
| M L Westedt | 1559 | 385 | 536 | 34 | 1.9k | |
| Taeko Ishii | 998 | 600 | 428 | 51 | 1.9k | |
| C. Gaich | 1257 | 447 | 647 | 40 | 1.8k | |
| Shihong Sheng | 721 | 741 | 645 | 27 | 1.4k | |
| Chuanbo Zang | 582 | 379 | 296 | 40 | 1.2k | |
| M J Cuadrado | 868 | 415 | 233 | 21 | 1.5k | |
| Karoline Sonneck | 401 | 1003 | 484 | 40 | 1.9k | |
| L. Settas | 1447 | 424 | 661 | 19 | 2.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...